Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States
Journal of Managed Care & Specialty Pharmacy · 2023
DOI: 10.18553/jmcp.2023.22331 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Managed Care & Specialty Pharmacy, 2023. Verfasst von Joseph E Biskupiak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy, University of Utah, Salt Lake City. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacotherapy, University of Utah, Salt Lake City.
- Global HEOR, IQVIA, Porto Salvo, Portugal.
- Ichan School of Medicine at Mount Sinai, New York City, NY.
- Children's Hospital, University of Colorado Denver, Aurora.
- Insulet, Acton, MA.
- Global HEOR, IQVIA, Zaventem, Belgium.
Zitieren
APA
Biskupiak, J. E., Ramos, M., Levy, C. J., Forlenza, G., Hopley, C., Boyd, J., Swift, D., Lamotte, M., & Brixner, D. I. (2023). Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States. Journal of Managed Care & Specialty Pharmacy. https://doi.org/10.18553/jmcp.2023.22331
Vancouver
Biskupiak JE, Ramos M, Levy CJ, Forlenza G, Hopley C, Boyd J, et al. Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States. Journal of Managed Care & Specialty Pharmacy. 2023. doi:10.18553/jmcp.2023.22331
BibTeX
@article{Biskupiak2023,
author = {Biskupiak, Joseph E and Ramos, Mafalda and Levy, Carol J and Forlenza, Greg and Hopley, Colin and Boyd, Jennifer and Swift, Dan and Lamotte, Mark and Brixner, Diana I},
title = {Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States},
journal = {Journal of Managed Care & Specialty Pharmacy},
year = {2023},
doi = {10.18553/jmcp.2023.22331}
}
EUVIMED